Cite
HARVARD Citation
, . et al. (2017). Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Antiretroviral-Experienced Subjects: Week 48 Analysis of AI438011, a Phase IIb, Randomized Controlled Trial. Antiviral therapy. 22 (3), pp. 215-223. [Online].